Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

3:46PM EST

World markets

Shanghai 3,127.44 +18.85 (0.61%)
Nikkei 225 17,635.14 +13.74 (0.08%)
Hang Seng Index 23,408.57 +291.94 (1.26%)
TSEC 9,095.00 +95.48 (1.06%)
FTSE 100 6,576.74 +31.47 (0.48%)
EURO STOXX 50 3,154.91 +13.63 (0.43%)
CAC 40 4,254.43 +12.78 (0.30%)
S&P TSX 14,431.46 -36.80 (-0.25%)
S&P/ASX 200 5,442.00 +103.40 (1.94%)
BSE Sensex 27,701.79 +329.95 (1.21%)
TA25 1,481.14 -6.39 (-0.43%)
SMI 9,033.45 +57.21 (0.64%)
ATX 2,153.60
IBOVESPA 50,120.86 +469.88 (0.95%)
SET 1,536.83 +22.48 (1.48%)
BIST100 85,143.76 +1,570.21 (1.88%)
IBEX 10,371.00 +7.40 (0.07%)
WIG 51,487.54 +190.42 (0.37%)
TASI 8,546.87
MERVAL 7,460.11 +134.82 (1.84%)

Currencies

EUR/USD 1.2227 +0.0002 (0.02%)
USD/JPY 119.9725 +0.4450 (0.37%)
GBP/USD 1.5582 -0.0046 (-0.29%)
USD/CAD 1.1642 +0.0031 (0.27%)
USD/HKD 7.7550 +0.0008 (0.01%)
USD/CNY 6.2198 -0.0026 (-0.04%)
AUD/USD 0.8132 -0.0015 (-0.19%)

Bonds

3 Month 0.01% -0.01 (-50.00%)
6 Month 0.10% -0.01 (-9.09%)
2 Year 0.64% 0.00 (0.00%)
5 Year 1.66% +0.01 (0.61%)
10 Year 2.16% -0.01 (-0.46%)
30 Year 2.75% -0.03 (-1.08%)
Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival
(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year ...
Drug Price War Takes Pharma Back To The Future  
US FDA approves AbbVie hepatitis C drug, costs $83319 for 12 weeks  
Market Chart
17,946.33 +141.53 (0.79%)
2,077.26 +6.61 (0.32%)
4,778.15 +12.77 (0.27%)

Top stories

China is stepping up its role as the lender of last resort to some of the world's most financially strapped countries. Chinese officials signaled Saturday that they are willing to expand a $24 billion currency swap program to help Russia weather the worst ...
U.S. stocks rose, sending the Standard & Poor's 500 Index toward a record, as a rally in technology shares offset a slump in biotechnology and the first drop in five days for energy companies.
Existing-home sales slid in November as housing supply showed some tightening, according to the National Association of Realtors on Monday.
A CSX freight train plows its way past the Cemetery Rd. overpass in Lancaster, N.Y. Wednesday, Nov. 19, 2014. Photo: AP Photo/Gary Wiepert,.
AP SEC MONEY MARKET FUNDS A F FILE USA DC Fast-growing money management firm F-Squared has agreed to pay $35 million and admit wrongdoing for defrauding investors with false ads about the firm's flagship product, a federal regulator said ...

Trends

Popular searches on GoogleChange Mkt Cap
OCN Ocwen Financial Corp -27.31% 2.52B
GILD Gilead Sciences, Inc. -14.22% 161.98B
CZR Caesars Entertainment Corp 11.79% 1.95B
GIL Gildan Activewear Inc (USA) 0.92% 7.01B
ACHN Achillion Pharmaceuticals, Inc. 8.06% 1.40B
ABBV AbbVie Inc -0.92% 107.96B
GI Gem International Resources Inc -45.10% 391,759.00
ACH Aluminum Corp. of China Limited (ADR) 0.78% 10.75B
TASR TASER International, Inc. 7.96% 1.26B
ABB ABB Ltd (ADR) 0.05% 49.45B

Sector summary

Sector Change % down / up
Energy -0.86%
Basic Materials -1.11%
Industrials +0.75%
Cyclical Cons. Goods ... +0.67%
Non-Cyclical Cons. Goods... +0.79%
Financials +0.37%
Healthcare -0.84%
Technology +1.04%
Telecommunications Servi... +0.98%
Utilities +0.45%